Australia, Aug. 28 -- IMUNEXUS THERAPEUTICS Ltd., owns the trademark (2618797) for 'IMUNEXIN' till Jan. 19, 2036.
Status: registered:
Registered/protected
Class: 5 [antitumour drugs; biochemical drugs; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for medical use; chemical preparations containing enzymes for pharmaceutical purposes; chemical products for pharmaceutical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents that facilitate the delivery of pharmaceutical preparations; drugs for medical purposes; drugs for medical use; enzyme preparations for medical purposes; enzymes for medical purposes; immunoassay reagents for medical use; immunoglobulins for medical purposes; immunological antibodies for medical purposes; immunological antibodies for medical use; immunostimulants; medicines; pharmaceutical drugs; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances; pharmaceutical preparations containing hormones for humans; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention of tumors; pharmaceutical preparations for use in immunomodulation therapies; pills [pharmaceuticals]; pills being pharmaceuticals]
Type of Mark: Word
Date of Acceptance: Feb. 3
Registration Advertised: Aug. 27
For further details contact APPLIED MARKS Pty. Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2618797.
Disclaimer: Curated by HT Syndication.
